+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Central Serous Chorioretinopathy

  • ID: 4659919
  • Book
  • March 2019
  • 662 Pages
  • Elsevier Science and Technology
1 of 3

Central Serous Chorioretinopathy discusses the mechanisms, pathogenesis and risk factors of CSCR, findings on various imaging modalities, available treatment options, and translational research into new treatment options for CSCR management. This comprehensive book is written for retina specialists and surgeons, researchers and clinical practitioners in sensory systems (vision), and ophthalmologists. Central Serous Chorioretinopathy (CSCR) is a common disorder across the world with a variable prognosis without any standard of care. Recently, advancements in imaging have led to a better understanding of the pathogenesis and mechanisms of this disease.

  • Summarizes the clinical understanding of CSCR
  • Explores pathogenesis, molecular mechanisms and risk factors
  • Compares angiography, tomography and additional imaging modalities
  • Identifies the best treatment practices
  • Discusses new laser, photodynamic and oral medication treatments, along with translational research into potential new treatments

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown
2 of 3

Section I. Basics 1. Pathophysiology of CSCR 2. Pachychoroid disease 3. Visual Dysfunction in Central Serous Chorioretinopathy 4. CSCR classification and its fallacies 5. Risk factors 6. Genetics

Section II. Imaging 7. Fundus autofluorescence 8. Fundus fluorescein angiography 9. Indocyanine green angiography 10. Optical coherence tomography 11. Optical coherence tomography angiography 12. Adaptive Optics Imaging in Central Serous Chorioretinopathy 13. Other imaging modalities in CSC 14. CSCR masquerades 15. Bullous variant and other atypical CSCR 16. Choroidal neovascularization associated with CSCR

Section III. Management 17. Conventional laser treatment in CSC 18. Subthreshold laser in CSCR 19. Photodynamic therapy in central serous chorioretinopathy 20. Oral Agents in the Treatment of Central Serous Chorioretinopathy 21. Other therapies in CSCR 22. Future research strategies in CSCR 23. Retro-Mode Imaging in Central Serous Chorioretinopathy

Note: Product cover images may vary from those shown
3 of 3
Chhablani, Jay
Dr. Chhablani is a consultant at the L.V. Prasad Eye Institute in Hyderabad, India. He is on the reviewing boards of all high impact Ophthalmology journals. He is on the editorial board of several journals including American Journal of Ophthalmology. He is a member of Global ONE network committee of American Academy of Ophthalmology and Asia Pacific Ocular Imaging Society. He has won several national and international awards. He has delivered inaugural Ian Constable lecture at Asia-Pacific Vitreo-Retina Society in 2016. He received Inaugural Namperumalsamy Young Researcher Award in 2018 by Vitreo-Retina Society of India.
Note: Product cover images may vary from those shown
Adroll
adroll